Trials / Completed
CompletedNCT02683928
To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis
A Phase IIa, Double-Blind, Randomised, Placebo-controlled, Exploratory Study to Evaluate the Safety, Biological Activity and Pharmacokinetics of GBR 830 in Adults With Moderate-to-Severe Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Ichnos Sciences SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of GBR 830 on biomarkers in atopic dermatitis to enable further studies in this indication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | GBR 830 | |
| BIOLOGICAL | Placebo |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-02-17
- Last updated
- 2020-05-18
- Results posted
- 2020-05-18
Locations
17 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02683928. Inclusion in this directory is not an endorsement.